scispace - formally typeset
D

Debopam Samanta

Researcher at University of Arkansas for Medical Sciences

Publications -  120
Citations -  718

Debopam Samanta is an academic researcher from University of Arkansas for Medical Sciences. The author has contributed to research in topics: Epilepsy & Medicine. The author has an hindex of 10, co-authored 103 publications receiving 371 citations. Previous affiliations of Debopam Samanta include Maulana Azad Medical College & University of Virginia.

Papers
More filters
Journal ArticleDOI

PCDH19-Related Epilepsy Syndrome: A Comprehensive Clinical Review

TL;DR: Clinical features of PCDH19-related epilepsy are reviewed based on a comprehensive literature review (MEDLINE using PubMed and OvidSP vendors with appropriate keywords to incorporate recent evidence), personal practice, and experience, to find opportunities in precision therapy.
Journal ArticleDOI

Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy.

TL;DR: Cannabidiol has better antiepileptic potential than tetrahydrocannabinol and may have a novel anticonvulsant effect, but it has broad drug-drug interactions with several agents, including inducer and inhibitor of CYP3A4 or CYP2C19.
Journal ArticleDOI

Underutilization of epilepsy surgery: Part I: A scoping review of barriers

TL;DR: In this paper, the authors compile known significant barriers to epilepsy surgery, originating from both patient/family-related factors and physician/health system components, including individual and epilepsy characteristics which bias towards continued preferential use of poorly effective medications, as well as patient perspectives and misconceptions of surgical risks and benefits.
Journal ArticleDOI

Sneddon Syndrome: A Comprehensive Overview.

TL;DR: Neuropsychiatric prognosis of SS is relatively poor with predominant deficits in the concentration, attention, visual perception, and visuospatial skills, and routine use of anti-inflammatory or immunosuppressive therapies is controversial.